Steven Paul, M.D.

Voyager Therapeutics

Contact Information

Steven Paul, M.D.
Cambridge , United States

Professional Information

President and CEO
Voyager Therapeutics

Education

Financial Disclosure

Member reports the following financial or other potential conflicts of interest:

Now CEO of a private neuroscience gene therapy company , owner of stock. Also former head of R&D at Lilly and also a shareholder of Lilly. Co-inventor of Solanezumab .